RNDr. Ludmila Šebejová, Ph.D.
Head, Biobank and CELSPAC Laboratories
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. D29/1S118
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7637 |
---|---|
E‑mail: |
Total number of publications: 77
2013
-
SF3B1 mutations frequently occur with both ATM mutations and TP53 mutations in CLL patients
Year: 2013, type: Conference abstract
-
Synthetic lethality in p53 mutated B-cell mylignancies: Chk-1 inhibition and DNA-PK inhibition effect in cell lines and primary CLL cells
Year: 2013, type: Conference abstract
-
The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 9, DOI
-
The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells
Leukemia & Lymphoma, year: 2013, volume: 54, edition: 8, DOI
-
TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab
Year: 2013, type: Conference abstract
-
TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab
Year: 2013, type: Conference abstract
2012
-
Analýza mutací v genech pro mikroRNA u pacientů s chronickou lymfocytární leukémií
Year: 2012, type: Conference abstract
-
Deep sequencing identifies TP53 mutations before their clonal selection by therapy in chronic lymphocytic leukemia
Year: 2012, type: Conference abstract
-
Defects of ATM gene involving mutation lead to complete elimination of ATM function in chronic lymphocytic leukemia
Year: 2012, type:
-
Defects of ATM gene involving mutation lead to complete elimination of ATM function in chronic lymphocytic leukemia
Year: 2012, type: Conference abstract